CALL/NOVO-NORDISK B/1400/0.1/20.12.24 Stock

Warrant

DE000GG5ES32

Market Closed - BOERSE MUENCHEN 14:25:30 2024-05-17 EDT
0.124 EUR -8.15% Intraday chart for CALL/NOVO-NORDISK B/1400/0.1/20.12.24
Current month-33.33%
1 month-45.13%
Date Price Change
24-05-17 0.124 -8.15%
24-05-16 0.135 -1.46%
24-05-15 0.137 +5.38%
24-05-14 0.13 -9.09%
24-05-13 0.143 +10.85%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 02:25 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Goldman Sachs
WKN GG5ES3
ISINDE000GG5ES32
Date issued 2024-03-18
Strike 1,400 kr
Maturity 2024-12-20 (217 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.271
Lowest since issue 0.104
Delta0x
Omega 0.000000
Premium0x
Gearing105.18x
Moneyness 0.6452
Difference Strike 496.7 kr
Difference Strike %+35.48%
Spread 0.03
Spread %23.08%
Intrinsic value 0.000000
Present value 0.1100

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
903.3 DKK
Average target price
909.2 DKK
Spread / Average Target
+0.66%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW